SafeHeal
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
40 Rue Du Louvre, Paris, Ile-de-France, ...Phone Number
(203) 444-0279Website
www.safeheal.comRevenue
$8.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SafeHeal
SafeHeal is an early-stage medical device company in Paris and created in 2015. The company develops Colovac, a device invented by a French digestive surgeon, Dr. Charam Khosrovani, to obviate the need for a digestive ostomy in patients undergoing colorectal surgery. The device is a flexible bypass sheath, intended to reduce any contact of fecal content at the anastomotic level, following colorectal surgery. Colovac is seamless, minimally invasive, and fully reversible. The device remains in place for 10 days, after which it is removed during an endoscopic procedure, without the need for a second surgical intervention. This enables patients to resume their normal life without having to bear an artificial anus or stoma for several months. SafeHeal was founded by MD Start II.Explore more
SafeHeal Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SafeHeal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at SafeHeal
Check out if SafeHeal is spiking on competitors!
SafeHeal, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on SafeHeal recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when SafeHeal launches new products
Click to see if SafeHeal had a recent Job posting/layoffs
Check if SafeHeal has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once SafeHeal has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined SafeHeal as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
SafeHeal is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SafeHeal is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SafeHeal.
SafeHeal financials insights
Gather financial insights about SafeHeal, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$7.4M
2022
Series B
$44.9M
2025
Series C
$51.5M
SafeHeal Tech Stack
A closer look at the technologies used by SafeHeal
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
SafeHeal News & Media
Paris-based SafeHeal® announces €10M extension of its Series C financing
SafeHeal® announced a €10 million extension of its oversubscribed €35 million Series C financing round. The extension is led by Asabys Partners through its Sabadell Asabys II fund, which joins a world-leading syndicate that includes Sofinnova Partners, Solar Eclipse, Gideon Strategic Partners, Polis, M&L Healthcare, and one of the world’s largest multinational life sciences corporations. […]Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®
Asabys joins SafeHeal’s global investor syndicateSafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology
Marketing approval allows imminent commercialization of the Colovac device in key EU markets NEW YORK, NY, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced …SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing - Business Wire
SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced a successful completion of an oversubscribed €35 million Series C e...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SafeHeal
Sign Up For FreeTo access detailed company insights
SafeHeal is an early-stage medical device company in Paris and created in 2015. The company develops Colovac, a device invented by a French digestive surgeon, Dr. Charam Khosrovani, to obviate the need for a digestive ostomy in patients undergoing colorectal surgery. The device is a flexible bypass sheath, intended to reduce any contact of fecal co... Read More
